Genetic testing for seriously ill infants in intensive care
Part of Genetic & congenital clinical trials.
This study offers genetic testing for infants under 18 months who are in intensive care with certain health problems that may be genetic. The goal is to find a genetic cause quickly, which could guide care and treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby is less than 18 months old
- Your baby is in intensive care (NICU or PICU)
- Your baby has birth defects, a major malformation needing treatment, a very abnormal heart test, very weak muscle tone, or a serious unexplained event with complications like infection, seizures, or needing CPR
- Your baby's illness is not already explained by a non-genetic cause or a known genetic condition
- You agree to genetic testing and data sharing
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses whole-genome sequencing (a DNA test that looks across the genome) for newborns in the intensive care unit when doctors suspect a genetic condition. It aims to help identify possible genetic causes of illness and improve understanding for families and clinicians.
This study looks at using rapid DNA testing (genomics) in newborns and children who are very sick in the hospital (NICU or PICU). The goal is to see if finding a genetic cause early can help guide treatment and improve outcomes.
This research study tests a new way to screen newborns for hundreds of genetic diseases using a sample of their blood or saliva. It aims to find conditions early so your baby can get the right care sooner.
This trial uses genetic testing to better understand the cause of a newborn’s birth defect and to help doctors choose more personalized treatment. It may help families get clearer answers and more targeted care.
This study looks at using whole genome sequencing in newborns and families with ongoing pregnancies, including those conceived naturally or with fertility treatments. It aims to better understand and manage genetic disease risks early.
This study uses a two-step genetic test (fast whole-genome sequencing followed by RNA testing if needed) to find the cause of unexplained, life-threatening conditions in newborns. The goal is to get a precise diagnosis faster, which could guide better care for your baby.
Hear when a new Whole Genome Sequencing trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.